Marco Herold

Dr. Marco Herold


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2016 in Nature
Verified
Journal Article
Closed access
AKAndrás Kotschy
András Kotschy
ZSZoltán Szlavik
Zoltán Szlavik
JMJames Murray
James Murray
JDJames Davidson
James Davidson
AMAna Leticia Maragno
Ana Leticia Maragno
OGOlivier Geneste
Olivier Geneste

1 September 2020 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
SBSammy Bedoui
Sammy Bedoui
MHMarco Herold
Marco Herold
ASAndreas Strasser
Andreas Strasser

1 December 2014 in Cell
Verified
Journal Article
Closed access
MWMichael J. White
Michael J. White
KMKate McArthur
Kate McArthur
DMDonald Metcalf
Donald Metcalf
RLRachael M. Lane
Rachael M. Lane
JCJohn C. Cambier
John C. Cambier
BKBenjamin T. Kile
Benjamin T. Kile

1 March 2015 in Cell Reports
Verified
Journal Article
Open access
BABrandon J. Aubrey
Brandon J. Aubrey
GKGemma L. Kelly
Gemma L. Kelly
AKAndrew J. Kueh
Andrew J. Kueh
MBMargs S. Brennan
Margs S. Brennan
LOLiam O’cOnnor
Liam O’cOnnor
MHMarco Herold
Marco Herold
The CRISPR/Cas9 technology enables the introduction of genomic alterations into almost any organism; however, systems for efficient and inducible gene modification have been lacking, especially for deletion of essential genes. Here, we describe a drug-inducible small guide RNA (sgRNA) vector system allowing for ubiquitous and efficient gene deletion in murine and human cells. This system mediates the efficient, temporally controlled deletion of MCL-1, both in vitro and in vivo, in human Burkitt lymphoma cell lines that require this anti-apoptotic BCL-2 protein for sustained survival and growth. Unexpectedly, repeated induction of the same sgRNA generated similar inactivating mutations in the human Mcl-1 gene due to low mutation variability exerted by the accompanying non-homologous end-joining (NHEJ) process. Finally, we were able to generate hematopoietic cell compartment-restricted Trp53-knockout mice, leading to the identification of cancer-promoting mutants of this critical tumor suppressor.

15 January 2012 in Genes & Development
Verified
Journal Article
Closed access
PDF file
SGStefan P. Glaser
Stefan P. Glaser
Erinna LeeErinna Lee
Erinna Lee
ETEvelyn Trounson
Evelyn Trounson
PBPhilippe Bouillet
Philippe Bouillet
Andrew H WeiAndrew H Wei
Andrew H Wei
ASAndreas Strasser
Andreas Strasser
Acute myeloid leukemia (AML) frequently relapses after initial treatment. Drug resistance in AML has been attributed to high levels of the anti-apoptotic Bcl-2 family members Bcl-xL and Mcl-1. Here we report that removal of Mcl-1, but not loss or pharmacological blockade of Bcl-xL, Bcl-2, or Bcl-w, caused the death of transformed AML and could cure disease in AML-afflicted mice. Enforced expression of selective inhibitors of prosurvival Bcl-2 family members revealed that Mcl-1 is critical for survival of human AML cells. Thus, targeting of Mcl-1 or regulators of its expression may be a useful strategy for the treatment of AML.

14 July 2015 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
PBPaul J. Baker
Paul J. Baker
DBDave Boucher
Dave Boucher
DBDamien Bierschenk
Damien Bierschenk
CTChristina Tebartz
Christina Tebartz
PWPaul G. Whitney
Paul G. Whitney
SMSeth L. Masters
Seth L. Masters
Humans encode two inflammatory caspases that detect cytoplasmic LPS, caspase‐4 and caspase‐5. When activated, these trigger pyroptotic cell death and caspase‐1‐dependent IL‐1β production; however the mechanism underlying this process is not yet confirmed. We now show that a specific NLRP3 inhibitor, MCC950, prevents caspase‐4/5‐dependent IL‐1β production elicited by transfected LPS. Given that both caspase‐4 and caspase‐5 can detect cytoplasmic LPS, it is possible that these proteins exhibit some degree of redundancy. Therefore, we generated human monocytic cell lines in which caspase‐4 and caspase‐5 were genetically deleted either individually or together. We found that the deletion of caspase‐4 suppressed cell death and IL‐1β production following transfection of LPS into the cytoplasm, or in response to infection with Salmonella typhimurium. Although deletion of caspase‐5 did not confer protection against transfected LPS, cell death and IL‐1β production were reduced after infection with Salmonella. Furthermore, double deletion of caspase‐4 and caspase‐5 had a synergistic effect in the context of Salmonella infection. Our results identify the NLRP3 inflammasome as the specific platform for IL‐1β maturation, downstream of cytoplasmic LPS detection by caspase‐4/5. We also show that both caspase‐4 and caspase‐5 are functionally important for appropriate responses to intracellular Gram‐negative bacteria.